AI Articles and Analysis in Healthcare

Explore articles and analysis related to artificial intelligence in healthcare, including coverage of diagnostics, pharma, drug development, medical billing, and more.

Artificial Intelligence at Geico-2x-2-min

Artificial Intelligence at Johnson & Johnson

In 2020, we wrote about the early but fertile stage of AI development at Johnson and Johnson. Since then, the COVID-19 pandemic and improvements to machine learning have forced important changes in how J&J is using artificial intelligence. 

Winning Buy-In for Life Sciences Manufacturing and Supply Chain Management-1x-min

Winning Buy-In for Life Sciences Manufacturing and Supply Chain Management – with Shreyas Becker of Sanofi

As life sciences organizations increasingly adopt AI to enhance productivity, streamline workflows, and improve quality, aligning AI initiatives with business objectives and evolving traditional return on investment (ROI) metrics have become essential strategies. These practices not only secure executive buy-in but also ensure sustained success in AI adoption.

Software Development
in the Evolving World of Medical Devices and Applications@2x

Software Development in the Evolving World of Medical Devices and Applications – with Urvashi Tyagi of ResMed

As technology advances, the lines between mobile applications and medical devices are blurring in ways that have healthcare leaders, software developers, and regulators alike facing new and unprecedented challenges.

Artificial Intelligence at Blue Cross Blue Shield-2x

Artificial Intelligence at Blue Cross Blue Shield

Blue Cross Blue Shield (BCBS) is a federation of 35 independent health insurance companies that provide coverage to over 100 million Americans. The organization's national headquarters is located in Chicago, Illinois, while individual BCBS companies operate in various states across the country.

Banner template-7-min

Artificial Intelligence at Lilly

Lilly and Company is a global pharmaceutical corporation founded in 1876 and headquartered in Indianapolis, Indiana. The company has offices in 18 countries and sells its products in approximately 125 countries worldwide. As of 2024, Lilly employs over 38,000 people globally and has an annual revenue of $34.12 billion. 

Driven Approaches 
to Infrastructure

Driving Patient Experiences Through Data Science-Driven Approaches to Infrastructure – with Xiong Liu of Novartis

Explainable AI models are essential in pharmaceutical R&D because they provide transparency and understanding of how AI-driven predictions are made. In drug discovery and development, stakeholders, including researchers, regulatory bodies, and healthcare professionals, need to trust and understand AI models' outputs to make informed decisions. Without explainability, AI models can be seen as "black boxes," leading to skepticism and reluctance to adopt these technologies in critical decision-making processes. 

V.1 – How AI Drives Drug Development Workflows and Value Chains Across Life Sciences Enterprises-1x-min

How AI Drives Drug Development Workflows and Value Chains Across Life Sciences Enterprises – with Leaders from Benevolent and Takeda

This article/interview analysis is sponsored by BenevolentAI and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Artificial Intelligence at Elevance Health-1-min

Artificial Intelligence at Elevance Health

Elevance Health is a health insurance provider headquartered in Indianapolis, Indiana. It was founded 20 years ago as a merger between Anthem and Wellpoint Health Networks. The company offers medical, dental, pharmaceutical, behavioral health, and long-term care plans.

Healthcare

Explore articles and analysis related to artificial intelligence in healthcare, including coverage of diagnostics, pharma, drug development, medical billing, and more.